Literature DB >> 23076686

Clinical features and management of pouchitis in Japanese ulcerative colitis patients.

Motoi Uchino1, Hiroki Ikeuchi, Hiroki Matsuoka, Toshihiro Bando, Yoshio Takesue, Naohiro Tomita.   

Abstract

PURPOSE: Pouchitis frequently occurs after restorative proctocolectomy for ulcerative colitis. This study evaluated the incidence and treatment of pouchitis in Japanese ulcerative colitis patients.
METHOD: This study reviewed the clinical data from 772 patients with pouch surgery between January 2000 and December 2010. Pouchitis was classified as acute or chronic pouchitis. The potential preoperative risk factors for overall and chronic pouchitis were analyzed using a logistic regression analysis. RESULT: The incidence of overall pouchitis and the cumulative risk of developing overall pouchitis were 10.0 % (77/772) and 10.7 % after 10 years, respectively. In addition, 74.0 % of all patients who developed overall pouchitis did so within 2 years after surgery. Chronic pouchitis occurred in 37.7 %. Although no independent risk factor for overall pouchitis was found, age at the onset of ulcerative colitis <26 years and surgical indications of toxic megacolon were found to be risk factors for chronic pouchitis and surgical indications of cancer/dysplasia were significantly associated with a low risk of overall pouchitis and patients with cancer/dysplasia were older than patients with other surgical indications (p < 0.01).
CONCLUSION: Immune abnormalities in younger onset patients or toxic megacolon may be more significant than surgical indications of cancer/dysplasia in elderly patients. Fundamental immune abnormalities may remain even after proctocolectomy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23076686     DOI: 10.1007/s00595-012-0377-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  25 in total

1.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

2.  Histologic predictors of pouchitis in patients with chronic ulcerative colitis.

Authors:  Rhonda K Yantiss; Heidi L Sapp; Francis A Farraye; Ola El-Zammar; Michael J O'Brien; Alex B Fruin; Arthur F Stucchi; Thomas P Brien; James M Becker; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

3.  Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy.

Authors:  R D Hurst; M Molinari; T P Chung; M Rubin; F Michelassi
Journal:  Arch Surg       Date:  1996-05

4.  A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.

Authors:  B Shen; J P Achkar; B A Lashner; A H Ormsby; F H Remzi; A Brzezinski; C L Bevins; M L Bambrick; D L Seidner; V W Fazio
Journal:  Inflamm Bowel Dis       Date:  2001-11       Impact factor: 5.325

5.  Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients?

Authors:  Nielce M de Paiva; Maria L S Ayrizono; Marciane Milanski; Andressa Coope; Luiza M F Oliveira; João J Fagundes; Lício A Velloso; Cláudio S R Coy; Raquel F Leal
Journal:  Int J Clin Exp Med       Date:  2011-09-15

6.  Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis.

Authors:  C Penna; R Dozois; W Tremaine; W Sandborn; N LaRusso; C Schleck; D Ilstrup
Journal:  Gut       Date:  1996-02       Impact factor: 23.059

7.  Short-term treatment with infliximab in chronic refractory pouchitis and ileitis.

Authors:  C Calabrese; P Gionchetti; F Rizzello; G Liguori; V Gabusi; R Tambasco; G Poggioli; F Pierangeli; M Campieri; G Di Febo
Journal:  Aliment Pharmacol Ther       Date:  2008-02-21       Impact factor: 8.171

8.  Diagnosing pouchitis: comparative validation of two scoring systems in routine follow-up.

Authors:  Udo A Heuschen; Erik H Allemeyer; Ulf Hinz; Frank Autschbach; Tanja Uehlein; Christian Herfarth; Gundi Heuschen
Journal:  Dis Colon Rectum       Date:  2002-06       Impact factor: 4.585

Review 9.  Pros and cons of antibiotic therapy for pouchitis.

Authors:  Udayakumar Navaneethan; Bo Shen
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2009-10       Impact factor: 3.869

10.  Clinical guidelines for the management of pouchitis.

Authors:  Darrell S Pardi; Geert D'Haens; Bo Shen; Simon Campbell; Paolo Gionchetti
Journal:  Inflamm Bowel Dis       Date:  2009-09       Impact factor: 5.325

View more
  9 in total

1.  Treatment strategy for preventing pouchitis as a postoperative complication of ulcerative colitis: the significance of the management of cuffitis.

Authors:  Takuzo Hashimoto; Michio Itabashi; Shinpei Ogawa; Tomoichiro Hirosawa; Yoshiko Bamba; Sanae Kaji; Mamiko Ubukata; Sayumi Nakao; Shingo Kameoka
Journal:  Surg Today       Date:  2014-07-15       Impact factor: 2.549

2.  The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis.

Authors:  Asuka Yasueda; Tsunekazu Mizushima; Riichiro Nezu; Ryoko Sumi; Mamoru Tanaka; Junichi Nishimura; Yasuyuki Kai; Masaki Hirota; Hideki Osawa; Kiyokazu Nakajima; Masaki Mori; Toshinori Ito
Journal:  Surg Today       Date:  2015-10-29       Impact factor: 2.549

3.  The functional outcome and factors influencing the quality of life after ileal pouch anal anastomosis in patients with ulcerative colitis.

Authors:  Kazuhiro Watanabe; Munenori Nagao; Hideyuki Suzuki; Hideaki Karasawa; Shinobu Ohnuma; Hiroaki Musha; Yuji Funayama; Takashi Kamei; Takeshi Naitoh; Michiaki Unno
Journal:  Surg Today       Date:  2017-12-12       Impact factor: 2.549

Review 4.  Pouchitis: insight into the pathogenesis and clinical aspects.

Authors:  Leandro Minatel Vidal de Negreiros; Lívia Bitencourt Pascoal; Lívia Moreira Genaro; Julian Furtado Silva; Bruno Lima Rodrigues; Michel Gardere Camargo; Carlos Augusto Real Martinez; Cláudio Saddy Rodrigues Coy; Maria de Lourdes Setsuko Ayrizono; João José Fagundes; Raquel Franco Leal
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

5.  Spontaneous and Immune Checkpoint Inhibitor-Induced Autoimmune Diseases: Analysis of Temporal Information by Using the Japanese Adverse Drug Event Report Database.

Authors:  Keiko Ogawa; Yoshihiro Kozuka; Hitomi Uno; Kosuke Utsumi; Osamu Noyori; Rumiko Hosoki
Journal:  Clin Drug Investig       Date:  2021-06-10       Impact factor: 2.859

6.  Meta-analysis of the association of extraintestinal manifestations with the development of pouchitis in patients with ulcerative colitis.

Authors:  K Hata; S Okada; T Shinagawa; T Toshiaki; K Kawai; H Nozawa
Journal:  BJS Open       Date:  2019-03-13

7.  Association between serum tumor necrosis factor-alpha level and the efficacy of infliximab for refractory pouchitis after restorative proctocolectomy in patients with ulcerative colitis.

Authors:  Motoi Uchino; Hiroki Ikeuchi; Toshihiro Bando; Akihiro Hirata; Teruhiro Chohno; Hirofumi Sasaki; Yuki Horio; Shiro Nakamura
Journal:  J Anus Rectum Colon       Date:  2018-05-25

Review 8.  A Personalized Approach to Managing Patients With an Ileal Pouch-Anal Anastomosis.

Authors:  Zaid S Ardalan; Miles P Sparrow
Journal:  Front Med (Lausanne)       Date:  2020-01-29

Review 9.  Chronic Antibiotic-Refractory Pouchitis: Management Challenges.

Authors:  An Outtier; Marc Ferrante
Journal:  Clin Exp Gastroenterol       Date:  2021-06-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.